# DERMATA THERAPEUTICS INC (DRMA)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/DRMA/

- Reporting holders: 13
- Reported value: $182.2K
- Shares held by institutions: 141,260 of 4,022,143 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [STATE STREET CORP](https://holderbook.com/funds/93751-state-street-corp/) | $48.4K | 37,494 | 0.0% | 1 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $26.1K | 20,203 | 0.0% | 2 |
| [Welch & Forbes LLC](https://holderbook.com/funds/105495-welch-forbes-llc/) | $25.8K | 20,000 | 0.0% | 2 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $21.7K | 16,796 | 0.0% | 4 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](https://holderbook.com/funds/1446194-susquehanna-international-group-llp/) | $20.6K | 15,989 | 0.0% | 1 |
| [XTX Topco Ltd](https://holderbook.com/funds/1828301-xtx-topco-ltd/) | $19.1K | 14,787 | 0.0% | 1 |
| [Advisory Alpha, LLC](https://holderbook.com/funds/1576762-advisory-alpha-llc/) | $12.9K | 10,000 | 0.0% | 1 |
| [Tower Research Capital LLC (TRC)](https://holderbook.com/funds/1533421-tower-research-capital-llc-trc/) | $5.0K | 3,860 | 0.0% | 4 |
| [MCF Advisors LLC](https://holderbook.com/funds/1602905-mcf-advisors-llc/) | $2.2K | 1,732 | 0.0% | 2 |
| [BARCLAYS PLC](https://holderbook.com/funds/312069-barclays-plc/) | $348 | 270 | 0.0% | 1 |
| [SBI Securities Co., Ltd.](https://holderbook.com/funds/1851815-sbi-securities-co-ltd/) | $130 | 101 | 0.0% | 4 |
| [HIGHLINE WEALTH PARTNERS LLC](https://holderbook.com/funds/2042654-highline-wealth-partners-llc/) | $34 | 26 | 0.0% | 1 |
| [MORGAN STANLEY](https://holderbook.com/funds/895421-morgan-stanley/) | $3 | 2 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 13 | $182.2K |
| Q1 2026 | 7 | $128.9K |
| Q4 2025 | 7 | $62.4K |
| Q3 2025 | 5 | $463.0K |
| Q2 2025 | 10 | $297.5K |
| Q1 2025 | 8 | $561.2K |
| Q4 2024 | 6 | $61.5K |
| Q3 2024 | 4 | $10.6K |
| Q2 2024 | 6 | $78.3K |
| Q1 2024 | 7 | $29.8K |
| Q4 2023 | 6 | $184.8K |
| Q3 2023 | 6 | $110.1K |